Corrigendum to “2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg”. [Int. Immunopharmacol. 108 (2022) 108769]
-
Published:2022-11
Issue:
Volume:112
Page:109259
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Qi Wen-Hui,Zhang Yan-Yan,Xing Kun,Hao Dong-Xia,Zhang Fei,Wang Rui-Ning,Bao Ming-Yue,Tian Meng-Yuan,Yang Ya-Na,Li Xing,Zhang Yuan
Subject
Pharmacology,Immunology,Immunology and Allergy